Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-809
Closed -$209K 145
2023
Q4
$209K Sell
809
-102
-11% -$25.1K 0.52% 134
2023
Q3
$234K Buy
+911
New +$244K 0.65% 94
2021
Q4
Sell
-1,004
Closed -$284K 291
2021
Q3
$284K Sell
1,004
-976
-49% -$320K 0.09% 272
2021
Q2
$686K Sell
1,980
-1,226
-38% -$371K 0.2% 204
2021
Q1
$897K Sell
3,206
-445
-12% -$120K 0.25% 195
2020
Q4
$894K Buy
3,651
+1,244
+52% +$321K 0.27% 192
2020
Q3
$683K Buy
+2,407
New +$671K 0.29% 163
2020
Q2
Sell
-68
Closed -$22K 279
2020
Q1
$22K Sell
68
-366
-84% -$111K ﹤0.01% 350
2019
Q4
$129K Sell
434
-536
-55% -$149K 0.02% 317
2019
Q3
$226K Buy
970
+255
+36% +$59.4K 0.04% 286
2019
Q2
$167K Sell
715
-422
-37% -$97.4K 0.03% 301
2019
Q1
$269K Buy
1,137
+567
+99% +$179K 0.05% 270
2018
Q4
$172K Sell
570
-11
-2% -$3.51K 0.04% 274
2018
Q3
$205K Buy
581
+257
+79% +$88.5K 0.05% 247
2018
Q2
$94K Buy
+324
New +$91.1K 0.02% 213

Other funds holding BIIB

Fort LP's BIIB Position: Q1 2024 in Review

Fort LP sold out of Biogen (BIIB) in Q1 2024, closing a stake of 809 shares — an estimated $209K sold.

Fort LP first reported a position in BIIB in Q2 2018 and held it in 15 quarters. The position peaked at $897K in Q1 2021. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Fort LP reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Fort LP sold 809 Biogen shares in Q1 2024, an estimated $209K.
  • Fort LP first reported a position in Biogen in Q2 2018 and held it in 15 quarters.
  • Fort LP's Biogen position peaked at $897K in Q1 2021.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Fort LP's 13F filing for Q1 2024, filed 14 May 2024.